The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer

Abstract Background A growing body of evidence suggests that inflammatory response markers such as the neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) are associated with outcomes of various malignancies. However, no study has reported the prognostic value of NLR and LMR...

Full description

Bibliographic Details
Main Authors: Yoji Miyahara, Shida Takashi, Yoshiaki Shimizu, Masayuki Ohtsuka
Format: Article
Language:English
Published: BMC 2020-04-01
Series:World Journal of Surgical Oncology
Subjects:
NLR
LMR
Online Access:http://link.springer.com/article/10.1186/s12957-020-01847-2
id doaj-e5172065f6ed4f1ab5dad1b1ed2116e3
record_format Article
spelling doaj-e5172065f6ed4f1ab5dad1b1ed2116e32020-11-25T02:04:55ZengBMCWorld Journal of Surgical Oncology1477-78192020-04-011811710.1186/s12957-020-01847-2The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancerYoji Miyahara0Shida Takashi1Yoshiaki Shimizu2Masayuki Ohtsuka3Department of Surgery, Japanese Red Cross Narita HospitalShida ClinicDepartment of Surgery, Japanese Red Cross Narita HospitalDepartment of General Surgery, Graduate School of Medicine, Chiba UniversityAbstract Background A growing body of evidence suggests that inflammatory response markers such as the neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) are associated with outcomes of various malignancies. However, no study has reported the prognostic value of NLR and LMR in patients with distal bile duct cancer (DBDC) to date. We investigated the prognostic significance of these inflammatory markers in patients with DBDC who underwent radical resection. Methods The study included 40 patients diagnosed with DBDC who underwent pancreaticoduodenectomy at Narita Red Cross Hospital between January 2000 and December 2017. The cutoff values for these markers were determined by receiver operating characteristic curve analysis. Survival curves are estimated for each group in the study considered separately using the Kaplan-Meier method. The association between overall survival (OS) and the NLR, LMR, and other prognostic factors was investigated using log-rank test and multivariate Cox proportional hazards regression analysis. Results Corresponding to the point with the maximum combined sensitivity and specificity on the ROC curve, the best cutoff value for NLR and LMR was determined to be 3.14 and 4.55, respectively. Most clinicopathological factors were not associated with the NLR and LMR based on these cutoff values. However, serum albumin levels were associated with both the NLR and LMR (P = 0.011 and P = 0.023, respectively), and serum carbohydrate antigen 19-9 (CA 19-9) levels were also associated with the LMR (P = 0.030). Univariate analysis showed that a high NLR (P < 0.001), low LMR (P = 0.002), hypoalbuminemia (P = 0.004), high serum CA 19-9 levels (P = 0.008), and lymph node metastasis (P = 0.033) were significantly associated with poor survival rates. Multivariate analysis showed that a high NLR (hazard ratio 5.799, 95% confidence interval 1.188–28.32, P = 0.030) and a low LMR (hazard ratio 4.837, 95% confidence interval 1.826–2.331, P = 0.025) were independent prognostic factors for OS. Conclusion Both NLR and LMR may serve as significant independent preoperative prognostic indicators of disease in patients with DBDC who undergo radical resection.http://link.springer.com/article/10.1186/s12957-020-01847-2NLRLMRDistal bile duct cancerPrognostic maker
collection DOAJ
language English
format Article
sources DOAJ
author Yoji Miyahara
Shida Takashi
Yoshiaki Shimizu
Masayuki Ohtsuka
spellingShingle Yoji Miyahara
Shida Takashi
Yoshiaki Shimizu
Masayuki Ohtsuka
The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer
World Journal of Surgical Oncology
NLR
LMR
Distal bile duct cancer
Prognostic maker
author_facet Yoji Miyahara
Shida Takashi
Yoshiaki Shimizu
Masayuki Ohtsuka
author_sort Yoji Miyahara
title The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer
title_short The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer
title_full The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer
title_fullStr The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer
title_full_unstemmed The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer
title_sort prognostic impact of neutrophil-to-lymphocyte ratio (nlr) and lymphocyte-to-monocyte ratio (lmr) in patients with distal bile duct cancer
publisher BMC
series World Journal of Surgical Oncology
issn 1477-7819
publishDate 2020-04-01
description Abstract Background A growing body of evidence suggests that inflammatory response markers such as the neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) are associated with outcomes of various malignancies. However, no study has reported the prognostic value of NLR and LMR in patients with distal bile duct cancer (DBDC) to date. We investigated the prognostic significance of these inflammatory markers in patients with DBDC who underwent radical resection. Methods The study included 40 patients diagnosed with DBDC who underwent pancreaticoduodenectomy at Narita Red Cross Hospital between January 2000 and December 2017. The cutoff values for these markers were determined by receiver operating characteristic curve analysis. Survival curves are estimated for each group in the study considered separately using the Kaplan-Meier method. The association between overall survival (OS) and the NLR, LMR, and other prognostic factors was investigated using log-rank test and multivariate Cox proportional hazards regression analysis. Results Corresponding to the point with the maximum combined sensitivity and specificity on the ROC curve, the best cutoff value for NLR and LMR was determined to be 3.14 and 4.55, respectively. Most clinicopathological factors were not associated with the NLR and LMR based on these cutoff values. However, serum albumin levels were associated with both the NLR and LMR (P = 0.011 and P = 0.023, respectively), and serum carbohydrate antigen 19-9 (CA 19-9) levels were also associated with the LMR (P = 0.030). Univariate analysis showed that a high NLR (P < 0.001), low LMR (P = 0.002), hypoalbuminemia (P = 0.004), high serum CA 19-9 levels (P = 0.008), and lymph node metastasis (P = 0.033) were significantly associated with poor survival rates. Multivariate analysis showed that a high NLR (hazard ratio 5.799, 95% confidence interval 1.188–28.32, P = 0.030) and a low LMR (hazard ratio 4.837, 95% confidence interval 1.826–2.331, P = 0.025) were independent prognostic factors for OS. Conclusion Both NLR and LMR may serve as significant independent preoperative prognostic indicators of disease in patients with DBDC who undergo radical resection.
topic NLR
LMR
Distal bile duct cancer
Prognostic maker
url http://link.springer.com/article/10.1186/s12957-020-01847-2
work_keys_str_mv AT yojimiyahara theprognosticimpactofneutrophiltolymphocyterationlrandlymphocytetomonocyteratiolmrinpatientswithdistalbileductcancer
AT shidatakashi theprognosticimpactofneutrophiltolymphocyterationlrandlymphocytetomonocyteratiolmrinpatientswithdistalbileductcancer
AT yoshiakishimizu theprognosticimpactofneutrophiltolymphocyterationlrandlymphocytetomonocyteratiolmrinpatientswithdistalbileductcancer
AT masayukiohtsuka theprognosticimpactofneutrophiltolymphocyterationlrandlymphocytetomonocyteratiolmrinpatientswithdistalbileductcancer
AT yojimiyahara prognosticimpactofneutrophiltolymphocyterationlrandlymphocytetomonocyteratiolmrinpatientswithdistalbileductcancer
AT shidatakashi prognosticimpactofneutrophiltolymphocyterationlrandlymphocytetomonocyteratiolmrinpatientswithdistalbileductcancer
AT yoshiakishimizu prognosticimpactofneutrophiltolymphocyterationlrandlymphocytetomonocyteratiolmrinpatientswithdistalbileductcancer
AT masayukiohtsuka prognosticimpactofneutrophiltolymphocyterationlrandlymphocytetomonocyteratiolmrinpatientswithdistalbileductcancer
_version_ 1724940363045535744